The Piros comment is interesting for sure. The liver trial also will complement this as we learn more about this. If bystander works there then just WOW!
By then minimally there will be data suggesting that PV10 works on both metatastic melanoma, a very tough disease, AND visceral cancer of liver. A single and safe drug that attacks mm and visceral cancer.
In parallel with that the study of mechanisms of action wil start.
Fellow board readers, can you see the game plan? And can you see what a smart pharma will do? |
